Shockwave Medical Inc (NASDAQ:SWAV) is in the spotlight today, after blue-chip pharmaceutical giant Johnson & Johnson (NYSE: JNJ) announced it would buy the company for $13.1 billion, boosting its portfolio of cardiovascular disease treatment devices.